摘要:
This invention pertains to certain active carbamic acid compounds which inhibit HDAC activity and which have the following formula: (I) A is an aryl group; Q1 is a covalent bond or an aryl leader group; J is a sulfonamide linkage selected from: —S(═O)2NR1— and —NR1S(═O)2—; R1 is a sulfonamido substituent; and, Q2 is an acid leader group; with the proviso that if J is —S(═O)2NR1—, then Q1 is an aryl leader group; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, and prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and, e.g., to inhibit proliferative conditions, such as cancer and psoriasis.
摘要:
This invention pertains to certain active carbamic acid compounds which inhibit HDAC activity and which have the following formula: (I) A is an aryl group; Q1 is a covalent bond or an aryl leader group; J is a sulfonamide linkage selected from: —S(═O)2NR1— and —NR1S(═O)2—; R1 is a sulfonamido substituent; and, Q2 is an acid leader group; with the proviso that if J is —S(═O)2NR1—, then Q1 is an aryl leader group; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, and prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and, e.g., to inhibit proliferative conditions, such as cancer and psoriasis.
摘要:
Dressing or bandage for protecting a wound accidentally incurred, surgical incision deliberately made in the skin, epidermal delivery of medication, or musculotherapy of a human being or animal, said bandage/dressing having the primary characteristic of being significantly atraumatic upon removal of same by virtue of a novel stringlike member that is intentionally incorporated into or debossed into the construction of said parent bandage/dressing in a multi-spiral geometry, said stringlike member firstly being pulled gently and progressively in multiple turns around the wound site or epidermal treatment area to in effect significantly reduce the area of remaining/undisturbed adhesive between the bandage/dressing and patient's skin before the bandage/dressing is peeled away from the skin in conventional manner and thus affording the patient a significantly less traumatic experience.
摘要:
An auxiliary weighted roller assembly attachable to a sports goal ground crossbar to stabilize the goal and to facilitate temporary or long term relocation for field maintenance, alternative field use, or storage consisting of a framework attachable to the crossbar and a pair of weighted rollers attached to the framework one each disposed on the front and rear of the crossbar and of sufficient diameter to raise the crossbar above the ground.
摘要:
An improved auxiliary weighted roller assembly attachable to a sports goal ground crossbar to stabilize the goal and to facilitate temporary or long term relocation for field maintenance, alternative field use, or storage consisting of a framework attachable to the crossbar and a pair of weighted rollers attached to the framework one each disposed on the front and rear of the crossbar of sufficient diameter to raise the crossbar above the ground, the improvement comprising devices to increase the strength of the clamping mechanism employed to attach the roller assembly and the goal ground crossbar.
摘要:
A turbo machine (1, 101), in particular turbine or compressor, includes a rotor (2, 102) which has at least one moving blade row (4, 104) with a plurality of moving blades (5, 105), and a stator (3) which has at least one guide vane row (6, 106) with a plurality of guide vanes (7, 107), at least one moving blade row (4, 104) having a shroud (8, 108). The shroud (8, 108) is designed to be self-supporting in such a way that it can at least partially absorb the centrifugal forces arising during operation and discharge them in the circumferential direction.
摘要:
This invention pertains to certain carbamic acid compounds which inhibit HDAC (histone deacetylase) activity of the following formula: The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, etc.
摘要:
A blade for a turbo machine has a blade section and a shroud element terminating the blade section in the blade section longitudinal direction. The blade section has a suction face and a pressure face. The shroud element extends essentially at right angles to the blade section longitudinal direction and has a first platform section projecting beyond the blade section and a second platform section projecting beyond the blade section. The platform sections are asymmetric with respect to one another. At least the first platform section of the shroud element is arranged at an additional inclination angle with respect to a normal alignment of the first platform section, with the additional inclination angle being in the opposite direction to the bending torque which acts on the first platform section during operation.
摘要:
The invention relates to an analytical technique for the quantitative determination of an analyte and a reagent solution useful in said quantitative determination. The analytical technique is conveniently adapted for quantitative determination of carbonyl and even more particularly adapted for finishing an alcohol produced in the Oxo Process.
摘要:
This invention pertains to certain carbamic acid compounds which inhibit HDAC (histone deacetylase) activity of the following formula: wherein: Cy is independently a cyclyl group; Q1 is independently a covalent bond or cyclyl leader group; the piperazin-1,4-diyl group is optionally substituted; J1 is independently a covalent bond or —C(═;O)—; J2 is independently —C(═O)— or —S(═O)2—; Q2 is independently an acid leader group; wherein: Cy is independently: C3-20carbocyclyl, C3-20heterocyclyl, or C5-20aryl; and is optionally substituted; Q1 is independently: a covalent bond; C1-7alkylene; or C1-7alkylene-X—C1-7alkylene, —X—C1-7alkylene, or C1-7alkylene-X—, wherein X is —O— or —S—; and is optionally substituted; Q2 is independently: C4-8alkylene; and is optionally substituted; and has a backbone length of at least 4 atoms; or: Q2 is independently: C5-20arylene; C5-20arylene-C1-7alkylene; C1-7alkylene-C5-20arylene; or, C1-7alkylene-C5-20arylene-C1-7alkylene; and is optionally substituted; and has a backbone length of at least 4 atoms; or a pharmaceutically acceptable salt, solvate, amide, ester, ether, chemically protected form, or prodrug thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, etc.